Literature DB >> 32588825

[Molecular mechanisms of action and physiological effects of the proinsulin C-peptide (a systematic review)].

O N Poteryaeva1, I F Usynin1.   

Abstract

The C-peptide is a fragment of proinsulin, the cleavage of which forms active insulin. In recent years, new information has appeared on the physiological effects of the C-peptide, indicating its positive effect on many organs and tissues, including the kidneys, nervous system, heart, vascular endothelium and blood microcirculation. Studies on experimental models of diabetes mellitus in animals, as well as clinical trials in patients with diabetes, have shown that the C-peptide has an important regulatory effect on the early stages of functional and structural disorders caused by this disease. The C-peptide exhibits its effects through binding to a specific receptor on the cell membrane and activation of downstream signaling pathways. Intracellular signaling involves G-proteins and Ca2+-dependent pathways, resulting in activation and increased expression of endothelial nitric oxide synthase, Na+/K+-ATPase and important transcription factors involved in apoptosis, anti-inflammatory and other intracellular defense mechanisms. This review gives an idea of the C-peptide as a bioactive endogenous peptide that has its own biological activity and therapeutic potential.

Entities:  

Keywords:  C-peptide; apoptosis; diabetic nephropathy; mechanism of action; neuropathy; review

Mesh:

Substances:

Year:  2020        PMID: 32588825     DOI: 10.18097/PBMC20206603196

Source DB:  PubMed          Journal:  Biomed Khim        ISSN: 2310-6905


  1 in total

1.  Streptozotocin-Induced Diabetes in a Mouse Model (BALB/c) Is Not an Effective Model for Research on Transplantation Procedures in the Treatment of Type 1 Diabetes.

Authors:  Michal Wszola; Marta Klak; Anna Kosowska; Grzegorz Tymicki; Andrzej Berman; Anna Adamiok-Ostrowska; Joanna Olkowska-Truchanowicz; Izabela Uhrynowska-Tyszkiewicz; Artur Kaminski
Journal:  Biomedicines       Date:  2021-11-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.